Clinical Trial

A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated March 7, 2025 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
To investigate the safety and tolerability after single and multiple ascending doses of MDR-001 Tablets administered orally in healthy participants and obese/ overweight participants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-12.
Trial Details
NCT Number NCT06778850
Lead Sponsor MindRank AI Ltd
Conditions Overweight and Obese Volunteers
Enrollment 131 participants
Start Date 2023-06-09
Primary Completion 2025-07-15 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-07